Last updated 3 months ago

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

370 patients around the world
Available in United States
Merck Sharp & Dohme Corp.
370Patients around the world
This study is for people with
Skin cancer
Melanoma
Lymphoma
Hodgkin lymphoma
Solid tumors
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy